🔗 Share this article

Grammy-winning soul vocalist D’Angelo passed away on October 14 at age 51 after a personal fight with pancreatic cancer.

“The brilliant light of our household has faded away for us in the present world,” his relatives stated. “After a lengthy and courageous struggle with cancer, we are heartbroken to declare that D’Angelo, recognized by his followers around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on music with his innovative neo-soul sound and collaborations with high-profile artists.

He launched his debut album, “Brown Sugar,” in 1995 to instant praise. The record achieved No. 4 on Billboard’s Top R&B Albums chart, went platinum later that year, and received several Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his artistic journey into the limelight. The album debuted at No. 1 on each of the R&B charts and the Billboard 200. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a reluctant one, in the public consciousness. The intimate portrayal featured the artist, notably bare to his waist, performing straight into the lens.

D’Angelo stepped back from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe car crash that put him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with another No. 1 debut on the R&B chart and a Grammy for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo had limited public appearances in the subsequent period.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his performance was canceled, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s health in the months leading up to his passing, he had reportedly been hospitalized for an extended period and in hospice for two weeks.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic cancer, one of the deadliest and hardest to prevent forms of the illness, on a brilliant talent whose life was ended too soon.

“We are saddened that he can only provide dear memories with his family, but we are forever thankful for the heritage of extraordinarily moving music he has left us,” his family expressed.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic cancer impacts the digestive organ, a tiny gland that generates the hormone insulin and plays an essential role in digestion, among additional roles. The size and location of the organ in the body make it more difficult to detect malignancy.

Although this cancer accounts for only about 3% of malignancy cases each year in the U.S., it is responsible for seven percent of malignancy fatalities.

Nearly seventy thousand individuals will be found to have pancreatic cancer and roughly fifty-two thousand will succumb to the disease in the year 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have few and poor therapies, and a narrow opportunity to make a meaningful impact on the well-being of people,” said a cancer specialist.

Because this disease seldom produces early symptoms, it’s frequently diagnosed only after the condition is advanced. Even when a patient has indicators they are usually vague and may be confused with a number of everyday ailments.

“Currently, there is no effective method to detect pancreatic cancer in the initial phases, except for listening to your body and speaking with your doctor if there are new or unusual symptoms,” said a medical director.

Common symptoms of pancreatic cancer encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s death is an outlier, as this malignancy is typically found in adults in the 65 to 75 range. However, numerous malignancies, including pancreatic cancer, have become increasingly prevalent in younger adults.

“This disease identified prior to fifty is considered uncommon, yet concerningly, doctors are beginning to see a rising count of younger individuals suffering from this condition,” said a specialist.

Family History Impacts Cancer Risk

In the absence of reliable screening tools for this malignancy, experts stressed the significance of understanding your family’s cancer history. Some risk factors, such as smoking and obesity also play a role in the development of pancreatic cancer.

Black individuals have the greatest occurrence of pancreatic cancer in the United States and are more prone to be diagnosed with untreatable disease.

“The first step toward lowering one’s risk of this condition is understanding personal risk factors. Individuals should examine their genetic background, hereditary factors, and medical conditions, such as diabetes, chronic pancreatitis, or overweight that may raise their vulnerability,” advised a specialist.

Inherited genetic elements are associated with as much as 10% of all pancreatic cancer cases. If a relative in your household has had this disease, you may want to think about DNA analysis.

“For individuals with a family history of pancreatic cancer or those carrying high risk DNA changes, checking may involve sophisticated scans such as MRI scans or internal ultrasound to find early changes in the organ,” he clarified.

For those wishing to lower their chance, habit adjustments may make a difference. The best action you can take to reduce your susceptibility of pancreatic cancer is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.

Excessive alcohol consumption is linked to pancreas inflammation, a risk factor for this malignancy, so limiting or avoiding alcohol may help lower your chance.

Managing your body mass or losing weight may also help decrease your susceptibility. People with excess weight are twenty percent more prone to develop this disease. This malignancy also occurs more often in those with blood sugar issues, and weight loss can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s grim outlook, there is still hope.

“We are doing better with treatments and more recent mixed drug treatments. There are emerging precision medicines that already are making an impact,” said a specialist.

For numerous individuals, however, awareness about this rare but {dev